Fatma ŞANLI, Neslişah BARLAK, Ahsen KILINÇ, Özel ÇAPIK, Abdülmelik AYTATLI, Ömer Faruk KARATAŞ

The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells

The European Research Journal

2020-Cilt: 6 - Sayı: 5

380-387

Larynx cancer, AZD5363, AKT, chemotherapy

69 81